Biosimilars Bill From Reps. Eshoo, Barton Gathers Steam In House Cmte.
Executive Summary
The counter-intuitive political dynamics of the follow-on biologics debate in the House Energy and Commerce Committee are on full display with the introduction of a bill from Rep. Anna Eshoo, D-Calif., and Joe Barton, R-Texas
You may also be interested in...
Follow-On Biologics Debate Creates Strange Bedfellows As Bills Emerge
Sen. David Vitter's strange bedfellows might help Democrats pick up his seat in 2010, but for now, they are hoping that his unusual alliances will help them advance healthcare reform
Follow-On Biologics Debate Creates Strange Bedfellows As Bills Emerge
Sen. David Vitter's strange bedfellows might help Democrats pick up his seat in 2010, but for now, they are hoping that his unusual alliances will help them advance healthcare reform
Back To The Future: Waxman Biosimilars Bill Offers New-Drug Style Exclusivity
With five years of market protection, but an extra year possible for an additional indication, the Commerce Committee chairman hopes to father another abbreviated industry.